IP Verse

Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency - EP2477645

The patent EP2477645 was granted to Aptalis Pharma on Aug 15, 2018. The application was originally filed on Sep 17, 2010 under application number EP10817867A. The patent is currently recorded with a legal status of "Revoked".

EP2477645

APTALIS PHARMA
Application Number
EP10817867A
Filing Date
Sep 17, 2010
Status
Revoked
May 4, 2024
Publication Date
Aug 15, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MATHYS & SQUIREMay 15, 2019MATHYS & SQUIREADMISSIBLE

Patent Citations (33) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005250817
DESCRIPTIONUS2006121017
DESCRIPTIONUS2006128587
DESCRIPTIONUS2007148151
DESCRIPTIONUS2007148152
DESCRIPTIONUS2007148153
DESCRIPTIONUS2008274174
DESCRIPTIONUS2008279953
DESCRIPTIONUS2008299185
DESCRIPTIONUS2009081184
DESCRIPTIONUS2009117180
DESCRIPTIONUS4079125
DESCRIPTIONUS5260074
DESCRIPTIONUS5302400
DESCRIPTIONUS5324514
DESCRIPTIONUS5378462
DESCRIPTIONUS5460812
DESCRIPTIONUS5578304
DESCRIPTIONUS5750104
DESCRIPTIONWO9728788
INTERNATIONAL-SEARCH-REPORTUS2006121017
INTERNATIONAL-SEARCH-REPORTUS2009117180
OPPOSITIONUS2004121010
OPPOSITIONUS2007025977
OPPOSITIONUS4447412
OPPOSITIONWO2004071374
OPPOSITIONWO2005048923
OPPOSITIONWO2005048996
OPPOSITIONWO2006119153
OPPOSITIONWO2008102264
OPPOSITIONWO2010037695
SEARCHUS2007148152
SEARCHUS2009081184

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- FITZSIMMONS et al., "High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.", New England Journal of Medicine, (19970000), vol. 336, pages 1283 - 1289
DESCRIPTION- LIEB et al., Aliment. Pharmacol. Ther, (20090000), vol. 29, pages 706 - 719
DESCRIPTION- SMYTH et al., "Fibrosing colonopathy in cystic fibrosis: results of a case-control study.", Lancet, (19950000), vol. 346, pages 1247 - 1251
DESCRIPTION- WINSTEAD et al., Pancreatology, (20090000), vol. 9, pages 344 - 350
OPPOSITION- Anonymous, "Aqueous Enteric Coating Polymer", Internet Archive Wayback Machine, (20080622), pages 1 - 4, URL: http://www.pharma-excipients.com/aqueous-enteric- coatinq-polvmer.html, XP055605853
OPPOSITION- Anonymous, "Cotazym E.C.S. 8 Generic Name: Pancrelipase", Drugs.com, URL: https://www.drugs.com/mmx/cotazym-e-c-s-8.html
OPPOSITION- "Coating of Pharmaceutical Dosage Forms /Passage/", Alfonso R. Gennaro, Remington, The Science and Practice of Pharmacy Volume II, 19th Edition, Mack Publishing company Easton, Pennsylvania, (19950000), pages 1653 - 1654, XP055605844
OPPOSITION- D. M. KRISHNAMURTY et al., "Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis", Therapeutics and Clinical Risk Management, (20090702), vol. 5, pages 507 - 520, XP055605832
OPPOSITION- D. KALNINS et al., "Combining unprotected pancreatic enzymes with pH-sensitive enteric-coated microspheres does not improve nutrient digestion in patients with cystic fibrosis", The Journal of Pediatrics, (20050000), vol. 146, pages 489 - 493, XP004841107
OPPOSITION- D. Y. GRAHAM, "Treatment of Steatorrhea in chronic Pancreatitis", Hospital Practice, (19860000), vol. 21, no. 1, pages 125 - 129, XP055605817
OPPOSITION- J. H. MEYER et al., "Mismatch of Duodenal Deliveries of Dietary Fat and Pancreatin from Enterically Coated Microspheres", Pancreas, (19970000), vol. 15, no. 3, pages 226 - 235, XP055605827
OPPOSITION- J.-C. DELCHIER et al., "Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two pancreatic enzyme preparations", Aliment. Pharmacol. Therap., (19910000), vol. 5, pages 365 - 378, XP055605822
OPPOSITION- A. ALOULOU et al., "In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability", Alimentary Pharmacology & Therapeutics, (20080000), vol. 27, no. 3, pages 283 - 292, XP055043242
SEARCH- A. ALOULOU ET AL, "In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, (20071029), vol. 27, no. 3, doi:10.1111/j.1365-2036.2007.03563.x, ISSN 0269-2813, pages 283 - 292, XP055043242 [A] 1-16 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents